期刊文献+

盐酸氨溴索对颈椎前路手术呼吸功能的影响 被引量:3

Influence of Ambroxol Hydrochloride on Respiratory Function of Cervical Anterior Approach Operation
下载PDF
导出
摘要 目的:探讨盐酸氨溴索对颈椎前路手术呼吸功能早期影响。方法:颈前路病人术后常规应用抗炎脱水治疗。试验组应用盐酸氨溴索60 mg,iv,tid,术后当日开始应用,连续6 d。对于肺部合并原发损伤的患者行盐酸氨溴索雾化吸入。对照组仅应用常规脱水抗炎药物治疗。结果:试验组与对照组进行比较,早期3 d内试验组优秀率为93%,对照组为71%,两组比较有统计学差异。3 d后试验组优秀率为97%,对照组为94%。结论:预防性应用盐酸氨溴索药物,可以预防颈前路手术呼吸功能并发症。 Objective: To evaluate the influence of ambroxol hydrochloride on respiratory function of the cervical anterior approach operation. Method: Antiinflammatory and dehydration conventional therapy were implemented for postoperative patients with cervical anterior approach. Vein injection of ambroxol hydrochloride 60mg for study group was used three times a clay postoperatively for six days. Ambroxol inhalation was used for patients with lung primarily disease. Regular dehydration and anti-inflammatory agent was ap- plied to the control group. Result: The excellent rate of experiment group was 93% and control group was 71% at the first three days. It had significant difference between two groups. The excellent rate of study group was 97% after three days, and control group was 94%. Conclusion: Anlbroxol hydrochloride for preventative purpose can prevent complication of respiratory function in cervical anterior approach operation.
出处 《中国药师》 CAS 2008年第8期970-971,共2页 China Pharmacist
关键词 盐酸氨溴索 呼吸功能 颈椎前路 Ambroxol hydrochloride Respiratory function Anterior cervical approach
  • 相关文献

参考文献3

二级参考文献19

  • 1陈新谦.新编药物学[M](第15版)[M].北京:人民卫生出版社,2004.48.
  • 2Lusuardi M,Cape 1 li A,Carli S,etal.Role of surfactant in chronic obst ructive pulmonary disease:therapeuticimplications.Respiration,1992,59(Suppl 1): 28-32.
  • 3Gillissen A,Nowak D.Characterization of N-acetylcysteine and ambroxol inanti-oxedant therapy.Respir Med,1998,92(4):609-623.
  • 4Houtmeyers E.Effects of drugs on mucus clearance.Eur Respir J,1999,1 4(2):452-467.
  • 5Zasshi NY.Effects of ambroxol HC1 on the guinea pig tracheal mucous secretion andthe rat pulmonary surfactant secretion.Uchida-M,1992,100(4):293-30 0.
  • 6Derelle J,Bertolo HE,Marchal F,et al.Respiratory evolution of patien t withmucoviscidosis treated with mucolytic agents plus dornase alfa.Arch-Pediatr,1998,5(4):371-377.
  • 7Nowak D,Antczak A,Krol M,et al.Antioxidant properties of ambroxol.Fr ee Radic BiolMed,1994,16(4):517-522.
  • 8Zwablo KG,Servais MD,Schmutzler W,et al.Ambroxol inhibits histamine release fromhuman adenoidal mast cells.Inflamm Res,1998,47(Suppl 1):S16-17.
  • 9Dorow P,Weiss T.Modification of mucociliary clearance by a combinati on oftheophylline with ambroxol and of ambroxol in monotherapy.Arzneimittelforschung,1988,38(6):828-830.
  • 10Tamaoki J.Ambroxol inhibits Na+ absorption by canine airway epithe lial cells inculture.J-Pharm-Pharmacol,1991,43(12):841-843.

共引文献187

同被引文献24

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部